Following allegations of manipulated data in its regulatory application, a division of the U.S. Food and Drug Administration (FDA) has proposed withdrawing Tavneos (avacopan), an oral treatment approved for the most common forms of ANCA-associated vasculitis (AAV), from the market. In a press announcement, the FDA’s Center…
Blood levels of transferrin (Tf), a protein that transports iron in the body, may serve as a useful biomarker for tracking the activity, treatment response, and outcomes of ANCA-associated vasculitis (AAV). That’s according to a new study by researchers in China that found that individuals with active AAV had…
Discussion
Living with ANCA-associated vasculitis often feels like a constant negotiation with our own bodies. Some days, our bodies are unpredictable, unreliable, or even working against us. Pain, fatigue, breathing challenges, and mobility changes make it difficult to feel at home in our own skin. But sometimes, during quieter moments,…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
